Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03364673 · ClinicalTrials.gov registry record · NA

Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer

A NA study, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT03364673: Completed NA study, sponsored by Dana-Farber Cancer Institute.

NCT03364673 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03364673, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

This research study will test whether using wearable fitness trackers with a social incentive, delivered through a game-based mobile health intervention, increases physical activity and quality of life in ovarian cancer survivors.

Primary Outcome

Feasibility will be defined as ≥60% of patients who participate in the pilot study complete the 24-week intervention

Interventions

  • OTHER Fitness Tracker
  • OTHER Social Incentive (Way to Health)

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2018-07-20
Est. Completion 2020-12-05
Phase NA
Dana-Farber Cancer Institute

781 total trials

What the finished NCT03364673 record still lists

NCT03364673 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Fitness Tracker is the first listed.

NCT03364673 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03364673 about?

NCT03364673 is a clinical study titled "Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer". This research study will test whether using wearable fitness trackers with a social incentive, delivered through a game-based mobile health intervention, increases physical activity and quality of life in ovarian cancer survivors.

What is the current status of trial NCT03364673?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-07-20. Estimated completion is 2020-12-05.

What interventions are being tested in trial NCT03364673?

The interventions under investigation include: Fitness Tracker (OTHER), Social Incentive (Way to Health) (OTHER).

Who is sponsoring clinical trial NCT03364673?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03364673's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03364673, the US trial registry maintained by the National Library of Medicine. NCT03364673 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.